These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35182166)

  • 61. Aptamers as a promising approach for the control of parasitic diseases.
    Ospina-Villa JD; Zamorano-Carrillo A; Castañón-Sánchez CA; Ramírez-Moreno E; Marchat LA
    Braz J Infect Dis; 2016; 20(6):610-618. PubMed ID: 27755981
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Selection strategy to generate aptamer pairs that bind to distinct sites on protein targets.
    Gong Q; Wang J; Ahmad KM; Csordas AT; Zhou J; Nie J; Stewart R; Thomson JA; Rossi JJ; Soh HT
    Anal Chem; 2012 Jun; 84(12):5365-71. PubMed ID: 22624874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Screening of DNA Signaling Aptamer from Multiple Candidates Obtained from SELEX with Next-generation Sequencing.
    Yoshitomi T; Wayama F; Kimura K; Wakui K; Furusho H; Yoshimoto K
    Anal Sci; 2019; 35(1):113-116. PubMed ID: 30626772
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Advances in binder identification and characterisation: the case of oligonucleotide aptamers.
    Taouji S; Dausse E; Evadé L; Di Primo C; Toulmé JJ; Chevet E
    N Biotechnol; 2012 Jun; 29(5):550-4. PubMed ID: 22178698
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aptamer-based nanobiosensors.
    Kim YS; Raston NH; Gu MB
    Biosens Bioelectron; 2016 Feb; 76():2-19. PubMed ID: 26139320
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 67. FSBC: fast string-based clustering for HT-SELEX data.
    Kato S; Ono T; Minagawa H; Horii K; Shiratori I; Waga I; Ito K; Aoki T
    BMC Bioinformatics; 2020 Jun; 21(1):263. PubMed ID: 32580745
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Searching the Sequence Space for Potent Aptamers Using SELEX in Silico.
    Zhou Q; Xia X; Luo Z; Liang H; Shakhnovich E
    J Chem Theory Comput; 2015 Dec; 11(12):5939-46. PubMed ID: 26642994
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Screening and identification of DNA aptamers against T-2 toxin assisted by graphene oxide.
    Chen X; Huang Y; Duan N; Wu S; Xia Y; Ma X; Zhu C; Jiang Y; Wang Z
    J Agric Food Chem; 2014 Oct; 62(42):10368-74. PubMed ID: 25265190
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Non-SELEX method for aptamer selection against β-casomorphin-7 peptide.
    Parashar A; Bhushan V; Mahanandia NC; Kumar S; Mohanty AK
    J Dairy Sci; 2022 Jul; 105(7):5545-5560. PubMed ID: 35534270
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Selection of DNA aptamers using atomic force microscopy.
    Miyachi Y; Shimizu N; Ogino C; Kondo A
    Nucleic Acids Res; 2010 Mar; 38(4):e21. PubMed ID: 19955232
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro selection of high-affinity DNA aptamers for streptavidin.
    Wang C; Yang G; Luo Z; Ding H
    Acta Biochim Biophys Sin (Shanghai); 2009 Apr; 41(4):335-40. PubMed ID: 19352549
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glycan-Imprinted Magnetic Nanoparticle-Based SELEX for Efficient Screening of Glycoprotein-Binding Aptamers.
    Ma Y; Li X; Li W; Liu Z
    ACS Appl Mater Interfaces; 2018 Nov; 10(47):40918-40926. PubMed ID: 30379519
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro selection and characterization of a DNA aptamer targeted to Prorocentrum minimum-A common harmful algae.
    Liu F; Zhang C; Duan Y; Ma J; Wang Y; Chen G
    Sci Total Environ; 2022 Jul; 830():154771. PubMed ID: 35339548
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent developments in protein and cell-targeted aptamer selection and applications.
    Liu J; You M; Pu Y; Liu H; Ye M; Tan W
    Curr Med Chem; 2011; 18(27):4117-25. PubMed ID: 21838693
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Selection of High-Affinity RNA Aptamers That Distinguish between Doxycycline and Tetracycline.
    Tickner ZJ; Zhong G; Sheptack KR; Farzan M
    Biochemistry; 2020 Sep; 59(37):3473-3486. PubMed ID: 32857495
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
    Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
    Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Isolating aptamers using capillary electrophoresis-SELEX (CE-SELEX).
    Mosing RK; Bowser MT
    Methods Mol Biol; 2009; 535():33-43. PubMed ID: 19377982
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of nucleic acid aptamers against lactate dehydrogenase via SELEX and high-throughput sequencing.
    Guo L; Song Y; Yuan Y; Chen J; Liang H; Guo F; Yu Z; Liang P; Wang Y; Wang P
    Anal Bioanal Chem; 2021 Jul; 413(17):4427-4439. PubMed ID: 34028561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.